Shop NLA Patient-Centered Management of Dyslipidemia: Part 2

Patient-Centered Management of Dyslipidemia: Part 2

Published: December 2015
$13.95
Print Copy Information:
  • 38 pages
  • Spiral Bound
  • 80# Aqueous Coating
  • 4.25" x 7.25"
  • Ships in 5 – 10 business days
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
  • Key Points 
  • Lifestyle 
  • General Management 
  • Hypertriglyceridemia 
  • Children and Adolescents 
  • Special Populations 
    • Women’s Health 
    • Older Patients 
    • Ethnic Groups 
    • Concurrent Conditions 
  • Residual Risk After Statins and Lifestyle Modification 
  • Charts 
    • Nutritional Recommendations 
    • Exercise/Physical Activity Recommendations 
    • Patient Adherence 
    • Team-Based Collaborative Care 
  • Figures 
    • Clinical Algorithm for Screening and Management of Elevated TG 
    • Dyslipidemia Algorithm Targeting LDL-C from the 2011 Expert Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents 
    • Statin Combination Therapy 
  • Tables 
    • Criteria for ASCVD Risk Assessment, Treatment Goals for Atherogenic Cholesterol, and Levels at Which to Consider Drug Therapy 
    • Changes from Baseline Lipoprotein Lipid Levels by Diet in Omniheart 
    • Predicted Effects of Macronutrient Replacement of Dietary Saturated Fatty Acids with PUFA, MUFA, and Carbohydrate on Lipoprotein Lipids Based on Results from Controlled Feeding Trials 
    • Evaluation of Hypertriglyceridemia 
    • Nutrition Therapy for Very High TG (≥500 mg/dL)/Chylomicron Clearing 
    • Acceptable, Borderline-high, and High Plasma Lipoprotein Lipids and Apolipoprotein Concentrations for Children and Adolescents 
    • Major Risk Factors and Conditions in Children and Adolescents 
    • International Diabetes Federation’s Definition of the At Risk Group and Metabolic Syndrome in Children and Adolescents 
    • Lipid Lowering Agents and Pregnancy Categories 
    • Criteria for Diagnosis of PCOS
    • Interactions Between ART and Statins
    • RA Treatments with Manufacturer Package Inserts Recommending Frequency of Lipid Measurements
    • Significant Risk Indicators 
    • Recommendations 
    • Statin Combination Therapies (Clinical trial results) 
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The National Lipid Association (NLA) is a nonprofit, multidisciplinary medical society focused on enhancing the practice of lipid management in clinical medicine. The NLA represents more than 3,500 members in the United States and provides continuing medical education for physicians and other healthcare professionals to advance professional development and attain certification in clinical lipidology. The NLA's public health mission is to help reduce deaths related to high cholesterol, and the Association defines "clinical lipidology" as "a multidisciplinary branch of medicine focusing on lipid and lipoprotein metabolism and their associated disorders."

Description

This pocket guide attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. This pocket guide should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.

Need help?